Skip to content
OpenCapital
Get started

Senti Biosciences SNTI Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Revenue$5.9MBeat by $3.1M
EPS-$0.67Beat by $2.46
Revenue estimate$2.8M
EPS estimate-$3.13

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$14.9K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$16.0KQ4 2025$22.0KMiss by $978.0K
Q4 2024$5.9MBeat by $3.1M

Diluted EPS

Q1 2026-$0.36Miss by $0.09Q4 2025-$0.38Beat by $0.05Q3 2025-$0.69Miss by $0.10Q2 2025-$0.56Beat by $0.34Q1 2025-$1.41Miss by $0.83
Q4 2024-$0.67Beat by $2.46

Ask the moment Senti Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Senti Biosciences report Q4 2024 earnings?
Senti Biosciences (SNTI) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Senti Biosciences's Q4 2024 revenue and EPS?
Senti Biosciences reported revenue of $5.9M and eps of $-0.67 for Q4 2024.
Did Senti Biosciences beat estimates in Q4 2024?
Revenue beat the consensus estimate of $2.8M by $3.1M. EPS beat the consensus estimate of $-3.13 by $2.46.
Where can I find Senti Biosciences's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001854270-25-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.